Ovarian Cancer Immunotherapy
contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more. Readers will also gain a better
understanding of the molecular and cellular events that underlie ovarian cancer immunology. This book is an ideal resource for clinicians, basic medical scientists, graduate basic medical science students, and medical students caring for patients with ovarian cancer, including attending surgeons and
physicians, and clinical fellows and residents in the disciplines of gynecologic oncology, medical oncology, and surgical oncology.
| Publisher Name | Oxford University Press USA |
|---|---|
| Author Name | Hagendorf, Col |
| Format | Audio |
| Bisac Subject Major | MED |
| Language | NG |
| Isbn 10 | 0190248203 |
| Isbn 13 | 9780190248208 |
| Target Age Group | min:NA, max:NA |
| Dimensions | 01.01" H x 00.07" L x 20.00" W |
| Page Count | 272 |
Samir A. Farghaly, MD, PhD is a Professor Obstetrics and Gynecology at the Joan and Sanford I. Weill Medical College, Graduate School of Medical Sciences; Sandra and Edward Meyer Cancer Center; and New York-Presbyterian Hospital/Weill Cornell Medical Center in New York, NY. He received his MD and
PhD in molecular biology from London University. Dr. Farghaly is the Founder and Editor-in Chief of Current Trends in Gynecologic Oncology, and The International Journal of Gynecological, Obstetrical, and Reproductive Medicine Research. He is a member of the editorial boards of 18 international
medical journals on Gynecological Cancers, Gene Expression and Therapy, Women's Health, and Gynecology.
